Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Significance of Collagenase 3 (Matrix Metalloproteinase 13) in Invasive Bladder Cancer: Correlation with Pathological Parameters

Rodríguez Faba O.b · Fernández Gómez J.M.a · Palou Redorta J.b · Escaf Barmadah S.a · Vizoso F.c · Villavicencio Mavrich H.b

Author affiliations

aDepartment of Urology and Pathology, University of Oviedo, Oviedo, bDepartment of Urology, Fundació Puigvert, Barcelona, and cDepartment of Surgery, Hospital of Jove, Gijón, Spain

Related Articles for ""

Urol Int 2007;78:140–144

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 19, 2005
Accepted: July 24, 2006
Published online: February 15, 2007
Issue release date: February 2007

Number of Print Pages: 5
Number of Figures: 3
Number of Tables: 2

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Purpose: To determine if collagenase 3 expression is associated with stage progression and prognosis of bladder cancer. Patients and Methods: Immunohistochemical staining for collagenase 3 was carried out on serial sections from specimens of 42 patients (32 males and 10 females) who underwent radical cystectomy for bladder cancer (median follow-up, 67.2 ± 5.99 months). Results: Immunohistochemical expression of collagenase 3 was detected in 13 (31%) patients. Pathological stage was pT2 in 12 (28.57%) patients, pT3a in 7 (16.6%), pT3b in 21 (50%) and pT4 in 2 (4.76%). Four tumours (9.52%) were grade II and 38 (90.47%) were grade III. Stage and tumours >3 cm in size were associated with bladder cancer progression-free survival and overall survival. We did not find any statistical differences with collagenase 3 expression related with stage and size. Conclusions: Immunohistochemical expression of matrix metalloproteinase 13 in invasive bladder cancer is not useful as marker for transformation and invasion. These findings should be evaluated in large multicentre prospective trials.

© 2007 S. Karger AG, Basel


References

  1. Brinckerhoff CE, Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002;3:207–214.
  2. Puente X, Sanchez LM, Overall CM, López-Otín C: Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 2003;4:544–558.
  3. Uria JA, López-Otín C: Matrilysin-2, a new matrix metalloproteinase expressed in human tumours and showing the minimal domain organization required for secretion, latency and activity. Cancer Res 2000;60:4745–4751.
  4. Folgueras AR, Pendás AM, Sánchez LM, López-Otín C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 2004;48:411–424.
  5. Epstein J, Amin M, Reuter V, Motoffi F: The world health organisation/international society of urological pathology consensus classification of urothelial neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435–1448.
  6. Bostrom PJ, Ravanti L, Reunanen N: Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer 2000;88:417–423.
  7. Hattori M, Ohno E, Kuramoto H: Immunocytochemistry of collagenase expression in transitional cell carcinoma of the bladder. Acta Cytol 2000;44:771–777.
  8. Manes S, Mira E, Barbacid M, et al: Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 1997;272:25706–25712.
  9. Yu C, Pan K, Xing D, et al: Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 2002;62:6430–6433.
  10. Balbin M, Fueyo A, Knauper V, et al: Collagenase-2 (MMP-8) expression in murine tissue-remodeling processes: analysis of its potential role in postpartum involution of the uterus. J Biol Chem 1998;273:23959–23968.
  11. Johanson N, Airola K, Grenman R: Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997;151:499–508.
    External Resources
  12. Airola K, Johansson N, Kariniemi A, et al: Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 1997;109:225–231.
  13. Uria JA, Balbin M, López JM: Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 1998;153:91–101.
  14. Nielsen BS, Rank F, López JM, et al: Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 2001;61:7091–7100.
  15. Nielsen BS, Rank F, López JM, et al: Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 2001;61:7091–7100.
  16. Dalbagni G, Genega E, Hashibe M: Cystectomy for bladder cancer: a contemporary series. J Urol 2001;165:1111–1116.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 19, 2005
Accepted: July 24, 2006
Published online: February 15, 2007
Issue release date: February 2007

Number of Print Pages: 5
Number of Figures: 3
Number of Tables: 2

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.